Furthermore, despite having no statistical significance, BN2 (26.09% vs. 4.17%, P > 0.05) and Other subtypes (60.87% vs. 37.5%, P > 0.05) accounted for the majority of CD5- DLBCL cases (Table 2). This evidence concerns the gene CD5 and diffuse large B-cell lymphoma.